CD5 |
P06127
|
CD5 molecule
|
|
2.3E-10 |
0.682 |
0.308 |
IGHV4-34 |
P06331
|
immunoglobulin heavy variable 4-34
|
|
|
0.716 |
0.308 |
PWWP3A |
Q2TAK8
|
PWWP domain containing 3A, DNA repair factor
|
|
2.2E-03 |
0.636 |
0.385 |
SLC35B2 |
Q8TB61
|
solute carrier family 35 member B2
|
|
7.1E-02 |
0.666 |
0.423 |
IGK |
|
immunoglobulin kappa locus
|
|
|
0.647 |
0.462 |
TCL1A |
P56279
|
T cell leukemia/lymphoma 1A
|
|
5.7E-10 |
0.558 |
0.500 |
TCL1B |
O95988
|
T cell leukemia/lymphoma 1B
|
|
1.0E-02 |
0.561 |
0.500 |
IBTK |
Q9P2D0
|
inhibitor of Bruton tyrosine kinase
|
|
2.2E-03 |
0.678 |
0.538 |
CLEC4D |
Q8WXI8
|
C-type lectin domain family 4 member D
|
|
2.5E-06 |
0.587 |
0.538 |
PRAME |
P78395
|
preferentially expressed antigen in melanoma
|
|
2.4E-07 |
0.531 |
0.577 |
CD22 |
P20273
|
CD22 molecule
|
|
0.80 |
0.556 |
0.615 |
CARD11 |
Q9BXL7
|
caspase recruitment domain family member 11
|
|
1.00 |
0.582 |
0.615 |
FCER2 |
P06734
|
Fc fragment of IgE receptor II
|
Receptor
|
7.6E-12 |
0.560 |
0.654 |
IGH |
|
immunoglobulin heavy locus
|
|
|
0.473 |
0.654 |
ACSBG1 |
Q96GR2
|
acyl-CoA synthetase bubblegum family member 1
|
Enzyme
|
4.0E-05 |
0.603 |
0.654 |
RAPH1 |
Q70E73
|
Ras association (RalGDS/AF-6) and pleckstrin homology domains 1
|
Receptor
|
1.00 |
0.593 |
0.654 |
CD70 |
P32970
|
CD70 molecule
|
|
1.0E-02 |
0.542 |
0.692 |
CDK2 |
P24941
|
cyclin dependent kinase 2
|
Kinase
|
0.61 |
0.456 |
0.692 |
PRDM1 |
O75626
|
PR/SET domain 1
|
|
0.96 |
0.538 |
0.731 |
CDK6 |
Q00534
|
cyclin dependent kinase 6
|
Kinase
|
0.98 |
0.471 |
0.731 |
JAK3 |
P52333
|
Janus kinase 3
|
Kinase
|
5.9E-06 |
0.505 |
0.731 |
BCL2L11 |
O43521
|
BCL2 like 11
|
|
0.89 |
0.510 |
0.731 |
TNFSF13B |
Q9Y275
|
TNF superfamily member 13b
|
|
0.98 |
0.460 |
0.731 |
CDKN1B |
P46527
|
cyclin dependent kinase inhibitor 1B
|
|
0.62 |
0.409 |
0.769 |
IRF4 |
Q15306
|
interferon regulatory factor 4
|
Transcription factor
|
0.86 |
0.491 |
0.769 |